NO770059L - - Google Patents

Info

Publication number: NO770059L
Authority: NO; Norway
Prior art keywords: isolating; lactate; separating; glycoproteins; glycoprotein
Prior art date: 1972-04-29

Application number

NO770059A

Other languages

English (en)

Norwegian (no)

Inventor

H Bohn

Original Assignee

Behringwerke Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1972-04-29

Filing date

1977-01-07

Publication date

1973-10-30

1972-04-29 Priority claimed from DE19722221261 external-priority patent/DE2221261A1/de

1973-10-30 Publication of NO770059L publication Critical patent/NO770059L/no

1977-01-07 Application filed by Behringwerke Ag filed Critical Behringwerke Ag

1977-01-07 Priority to NO770059A priority Critical patent/NO770059L/no

Links

FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
239000000243 solution Substances 0.000 claims description 15
239000002244 precipitate Substances 0.000 claims description 11
238000000034 method Methods 0.000 claims description 8
239000011780 sodium chloride Substances 0.000 claims description 8
210000002966 serum Anatomy 0.000 claims description 7
201000010099 disease Diseases 0.000 claims description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
108090000623 proteins and genes Proteins 0.000 claims description 5
102000004169 proteins and genes Human genes 0.000 claims description 5
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
235000011130 ammonium sulphate Nutrition 0.000 claims description 4
210000002826 placenta Anatomy 0.000 claims description 4
238000001556 precipitation Methods 0.000 claims description 4
210000004369 blood Anatomy 0.000 claims description 3
239000008280 blood Substances 0.000 claims description 3
238000004519 manufacturing process Methods 0.000 claims description 3
239000007787 solid Substances 0.000 claims description 3
102000003886 Glycoproteins Human genes 0.000 claims description 2
108090000288 Glycoproteins Proteins 0.000 claims description 2
230000002378 acidificating effect Effects 0.000 claims description 2
-1 dimethoxy-acridine lactate Chemical compound 0.000 claims description 2
238000013508 migration Methods 0.000 claims description 2
230000005012 migration Effects 0.000 claims description 2
239000012266 salt solution Substances 0.000 claims description 2
238000002560 therapeutic procedure Methods 0.000 claims description 2
VRQURTHVUQBIMS-UHFFFAOYSA-N 2-acridin-1-yloxyethane-1,1-diamine;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1=CC=C2C=C3C(OCC(N)N)=CC=CC3=NC2=C1 VRQURTHVUQBIMS-UHFFFAOYSA-N 0.000 claims 2
239000003153 chemical reaction reagent Substances 0.000 claims 2
229920001817 Agar Polymers 0.000 claims 1
238000003748 differential diagnosis Methods 0.000 claims 1
238000012544 monitoring process Methods 0.000 claims 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
239000000872 buffer Substances 0.000 description 5
238000002955 isolation Methods 0.000 description 4
238000007693 zone electrophoresis Methods 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
238000001962 electrophoresis Methods 0.000 description 3
238000001914 filtration Methods 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
229920002307 Dextran Polymers 0.000 description 2
229920005654 Sephadex Polymers 0.000 description 2
239000012507 Sephadex™ Substances 0.000 description 2
DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
239000001166 ammonium sulphate Substances 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
239000012153 distilled water Substances 0.000 description 2
238000010828 elution Methods 0.000 description 2
108010074605 gamma-Globulins Proteins 0.000 description 2
230000001900 immune effect Effects 0.000 description 2
238000000746 purification Methods 0.000 description 2
239000002023 wood Substances 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
241000219112 Cucumis Species 0.000 description 1
235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
102100025027 E3 ubiquitin-protein ligase TRIM69 Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
101000830203 Homo sapiens E3 ubiquitin-protein ligase TRIM69 Proteins 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
206010038743 Restlessness Diseases 0.000 description 1
FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000003926 acrylamides Chemical class 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
235000012538 ammonium bicarbonate Nutrition 0.000 description 1
239000001099 ammonium carbonate Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
238000005352 clarification Methods 0.000 description 1
238000001514 detection method Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
235000013305 food Nutrition 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
238000009413 insulation Methods 0.000 description 1
229920000915 polyvinyl chloride Polymers 0.000 description 1
239000004800 polyvinyl chloride Substances 0.000 description 1
239000002243 precursor Substances 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
230000000750 progressive effect Effects 0.000 description 1
231100000241 scar Toxicity 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000006228 supernatant Substances 0.000 description 1

Landscapes

Peptides Or Proteins (AREA)

NO770059A 1972-04-29 1977-01-07 NO770059L (de)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO770059A NO770059L (de)	1972-04-29	1977-01-07

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE19722221261 DE2221261A1 (de)	1972-04-29	1972-04-29	Ap-glykoproteine und verfahren zu ihrer isolierung
NO175873		1973-04-27
NO770059A NO770059L (de)	1972-04-29	1977-01-07

Publications (1)

Publication Number	Publication Date
NO770059L true NO770059L (de)	1973-10-30

Family

ID=27184381

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO770059A NO770059L (de)	1972-04-29	1977-01-07

Country Status (1)

Country	Link
NO (1)	NO770059L (de)

1977
- 1977-01-07 NO NO770059A patent/NO770059L/no unknown

Similar Documents

Publication	Publication Date	Title
MAcLEOD et al.	1941	The occurrence during acute infections of a protein not normally present in the blood: III. Immunological properties of the C-reactive protein and its differentiation from normal blood proteins
Dunne et al.	1981	Identification and partial purification of an antigen (ω1 from Schistosoma mansoni eggs which is putatively hepatotoxic in T-cell deprived mice
Morgan et al.	1941	Studies in immunochemistry: The use of phenol and of alkali in the degradation of antigenic material isolated from Bact. dysenteriae (Shiga) 1
Jockers-Wretou et al.	1975	Quantitation of creatine kinase isoenzymes in human tissues and sera by an immunological method
Crittenden et al.	1984	Carbohydrate-binding protein 35: identification of the galactose-specific lectin in various tissues of mice
James et al.	1967	Studies on a unique diagnostic serum globulin in papular mucinosis (lichen myxedematosus)
Diaz et al.	1977	Bullous pemphigoid antigen: isolation from normal human skin
Ooi et al.	1976	Classical complement pathway activation in membranoproliferative glomerulonephritis
Beutler et al.	1975	Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes
US4041021A (en)	1977-08-09	AP-glycoproteins and process for isolating them
Chow et al.	1935	The purification of the antibodies in type I anti-pneumococcus serum, and the chemical nature of the type-specific precipitin reaction
Curtain	1955	The nature of the protein in the hyaluronic complex of bovine synovial fluid
Ling et al.	1995	A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement
DE3425186A1 (de)	1985-01-24	Humanproteine, verfahren zu deren herstellung und diese enthaltende testkits
Kawahara et al.	1985	Solubilization and characterization of putative alpha-2 adrenergic isoceptors from the human platelet and the rat cerebral cortex.
Morgan et al.	1945	A specific blood group O substance
NO770059L (de)	1973-10-30
Bombardieri et al.	1974	An evaluation of an agar gel diffusion test with crude and purified antigens in the diagnosis of hydatid disease
Sawitsky et al.	1948	A study of cholinesterase activity in the blood of normal subjects
EP0410816B1 (de)	1998-01-14	Nachweis von heparinbindenden Seminalproteinen
Cheung et al.	1979	Purification and properties of the hemagglutinin from Wistaria floribunda seeds
Boursnell et al.	1939	Studies on Bayer 205 (Germanin) and Antrypol: The retention of the drug in the animal body
JPS60215629A (ja)	1985-10-29	組織蛋白質ｐｐ↓２↓１およびその取得法
Miller et al.	1952	Myosin preparations from the rabbit, rat and mouse
KR100379189B1 (ko)	2003-04-08	헬리코박터 파이로리에 의한 위질환 치료제용 조성물 및그 탐색방법